AU2002221935A1 - Use of low molecular heparin for treating osteoarthritis - Google Patents

Use of low molecular heparin for treating osteoarthritis

Info

Publication number
AU2002221935A1
AU2002221935A1 AU2002221935A AU2193502A AU2002221935A1 AU 2002221935 A1 AU2002221935 A1 AU 2002221935A1 AU 2002221935 A AU2002221935 A AU 2002221935A AU 2193502 A AU2193502 A AU 2193502A AU 2002221935 A1 AU2002221935 A1 AU 2002221935A1
Authority
AU
Australia
Prior art keywords
low molecular
treating osteoarthritis
molecular heparin
heparin
osteoarthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221935A
Inventor
Eckart Bartnik
Philipp Haus-Seuffert
Christine Hoerber
Christopher Kern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of AU2002221935A1 publication Critical patent/AU2002221935A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002221935A 2000-12-16 2001-12-05 Use of low molecular heparin for treating osteoarthritis Abandoned AU2002221935A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10063006 2000-12-16
DE10063006 2000-12-16
PCT/EP2001/014261 WO2002047696A1 (en) 2000-12-16 2001-12-05 Use of low molecular heparin for treating osteoarthritis

Publications (1)

Publication Number Publication Date
AU2002221935A1 true AU2002221935A1 (en) 2002-06-24

Family

ID=7667600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221935A Abandoned AU2002221935A1 (en) 2000-12-16 2001-12-05 Use of low molecular heparin for treating osteoarthritis

Country Status (11)

Country Link
US (1) US20020128226A1 (en)
EP (1) EP1345612B1 (en)
AR (1) AR031909A1 (en)
AT (1) ATE290874T1 (en)
AU (1) AU2002221935A1 (en)
CA (1) CA2431709A1 (en)
DE (1) DE50105650D1 (en)
ES (1) ES2238383T3 (en)
MX (1) MXPA03004965A (en)
PT (1) PT1345612E (en)
WO (1) WO2002047696A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2413847A (en) * 2004-04-26 2005-11-09 Daniolabs Ltd Bone disease models
CN101112380A (en) * 2006-07-24 2008-01-30 凌沛学 Articular cavity inner injecting and administering preparations containing low-molecular-weight heparin or the low-molecular-weight heparin salt
ES2658964T3 (en) 2007-08-03 2018-03-13 Nucitec S.A. De C.V.  Compositions and methods for the treatment and prevention of osteoarthritis
IT1401253B1 (en) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino USE OF SULODEXIDE FOR THE REDUCTION OF MATRIX METALLOPROTEINASE.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889851A (en) * 1986-11-21 1989-12-26 Fujisawa Pharmaceutical Co, Ltd. Benzothiadiazine compounds, and pharmaceutical composition comprising the same
FR2663639B1 (en) 1990-06-26 1994-03-18 Rhone Poulenc Sante LOW MOLECULAR WEIGHT POLYSACCHARIDE BLENDS PROCESS FOR PREPARATION AND USE.
WO1992019249A1 (en) * 1991-05-02 1992-11-12 Yeda Research And Development Co. Ltd. Compositions for the prevention and/or treatment of pathological processes
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
WO1994028889A1 (en) 1993-06-08 1994-12-22 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
CA2138305A1 (en) * 1993-12-28 1995-06-29 Naohito Ohashi Tumor necrosis factor production inhibitors
IL127851A0 (en) * 1998-12-30 1999-10-28 Applied Research Systems Inhibition of TNF activity
US6291457B1 (en) * 1999-07-01 2001-09-18 Merck & Co., Inc. Compounds having cytokine inhibitory activity
FR2800074B1 (en) * 1999-10-22 2001-12-21 Aventis Pharma Sa NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE10026699A1 (en) * 2000-05-30 2001-12-06 Basf Ag Formulation based on heparin, glycosaminoglycan or heparinoid and use of the formulation and the formulation base
JP2004523479A (en) * 2000-10-18 2004-08-05 マサチューセッツ　インスティテュート　オブ　テクノロジー Methods and products for pulmonary delivery of polysaccharides

Also Published As

Publication number Publication date
CA2431709A1 (en) 2002-06-20
EP1345612A1 (en) 2003-09-24
ES2238383T3 (en) 2005-09-01
PT1345612E (en) 2005-06-30
US20020128226A1 (en) 2002-09-12
WO2002047696A1 (en) 2002-06-20
DE50105650D1 (en) 2005-04-21
ATE290874T1 (en) 2005-04-15
EP1345612B1 (en) 2005-03-16
MXPA03004965A (en) 2003-09-25
AR031909A1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2002211686A1 (en) Bandage using molecular sieves
AU2003216416A1 (en) Patella resection guide
AU2002231182A1 (en) Surgical articles
AU2001266068A1 (en) Treatment of mineral substrates
AU2000266138A1 (en) Method of making elastic articles having improved heat-resistance
AU2002258637A1 (en) Biodegradable, electrically conductiong polymer for tissue engineering applications
AU2001267064A1 (en) Surgical table
AU2002366084A1 (en) Absorbent articles having improved stretchability
AU2002342613A1 (en) Treatment for wounds
AU2002360089A1 (en) Polymer derivatives for treating metals
AUPR259301A0 (en) Polymers having co-continuous architecture
AU2001239858A1 (en) Wastewater treatment process
AU2001286983A1 (en) Method of treatment
AU2001276749A1 (en) Polymer composition
AU8952201A (en) Use of n-desulfated heparin for treating or preventing inflammations
AU4770700A (en) Bone resection guide
AU2002245225A1 (en) Repeat-free probes for molecular cytogenetics
AU2002221935A1 (en) Use of low molecular heparin for treating osteoarthritis
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AU2002216930A1 (en) System for treating vascular adhesions
AU2001262177A1 (en) Method of treatment
AU2001245092A1 (en) Sterilization of elongate lumens
AU2001258675A1 (en) Treating infections
AU3759800A (en) Treatment of premenstrual syndrome